“…4,13,29,30 Similarly, observations about the genetic and molecular make-up of bladder urothelial neoplasms in young patients have varied. [31][32][33][34][35] One reason for this variability is the differing criteria to define "young" patients in published series which have used cut-offs of 20, 30, or 40 to 45 years of age. 3,4,6,13,[26][27][28][29][30][31][32][33][34][35] Owing to conflicting opinions, currently there are no current standardized recommendations in terms of diagnostic approach and management specific for young or pediatric patients with bladder urothelial neoplasms.…”